메뉴 건너뛰기




Volumn 12, Issue 1, 2015, Pages 40-42

Hepatitis B in 2014 : HBV research moves forward-receptors and reactivation

Author keywords

[No Author keywords available]

Indexed keywords


EID: 84926076148     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2014.226     Document Type: Review
Times cited : (7)

References (10)
  • 1
    • 84879327902 scopus 로고    scopus 로고
    • Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus
    • Yan, H. et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Elife 1, e00049 (2012).
    • (2012) Elife , vol.1 , pp. e00049
    • Yan, H.1
  • 2
    • 84894230843 scopus 로고    scopus 로고
    • Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide
    • Yan, H. et al. Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide. J. Virol. 6, 3273-3284 (2014).
    • (2014) J. Virol. , vol.6 , pp. 3273-3284
    • Yan, H.1
  • 3
    • 84899486063 scopus 로고    scopus 로고
    • Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP)
    • Watashi, K. et al. Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP). Hepatology 59, 1726-1737 (2014).
    • (2014) Hepatology , vol.59 , pp. 1726-1737
    • Watashi, K.1
  • 4
    • 84894237342 scopus 로고    scopus 로고
    • Hepatitis B and D viruses exploit sodium taurocholate co-Transporting polypeptide for species-specific entry into hepatocytes
    • Ni, Y. et al. Hepatitis B and D viruses exploit sodium taurocholate co-Transporting polypeptide for species-specific entry into hepatocytes. Gastroenterology 146, 1070-1083 (2014).
    • (2014) Gastroenterology , vol.146 , pp. 1070-1083
    • Ni, Y.1
  • 5
    • 84902973225 scopus 로고    scopus 로고
    • Strategies to inhibit entry of HBV and HDV into hepatocytes
    • Urban, S., Bartenschlager, R., Kubitz, R., & Zoulim, F. Strategies to inhibit entry of HBV and HDV into hepatocytes. Gastroenterology 147, 48-64 (2014).
    • (2014) Gastroenterology , vol.147 , pp. 48-64
    • Urban, S.1    Bartenschlager, R.2    Kubitz, R.3    Zoulim, F.4
  • 6
    • 0028047191 scopus 로고
    • Hepatitis B virus persistence after recovery from acute viral hepatitis
    • Michalak, T. I., Pasquinelli, C., Guilhot, S., & Chisari, F. V. Hepatitis B virus persistence after recovery from acute viral hepatitis. J. Clin. Invest. 93, 230-239 (1994).
    • (1994) J. Clin. Invest. , vol.93 , pp. 230-239
    • Michalak, T.I.1    Pasquinelli, C.2    Guilhot, S.3    Chisari, F.V.4
  • 7
    • 0035804282 scopus 로고    scopus 로고
    • Acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was receiving rituximab
    • Dervite, I., Hober, D., & Morel, P. Acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was receiving rituximab. N. Engl. J. Med. 344, 68-69 (2001).
    • (2001) N. Engl. J. Med. , vol.344 , pp. 68-69
    • Dervite, I.1    Hober, D.2    Morel, P.3
  • 8
    • 79551543248 scopus 로고    scopus 로고
    • Rituximab-Associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: Meta-Analysis and examination of FDA safety reports
    • Evens, A. M. et al. Rituximab-Associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-Analysis and examination of FDA safety reports. Ann. Oncol. 22, 1170-1180 (2011).
    • (2011) Ann. Oncol. , vol.22 , pp. 1170-1180
    • Evens, A.M.1
  • 9
    • 84901591515 scopus 로고    scopus 로고
    • Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study
    • Hsu, C. et al. Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: a prospective study. Hepatology 59, 2092-2100 (2014).
    • (2014) Hepatology , vol.59 , pp. 2092-2100
    • Hsu, C.1
  • 10
    • 84911424291 scopus 로고    scopus 로고
    • Hepatitis B reactivation in patients with previous hepatitis B virus exposure undergoing rituximab-containing chemotherapy for lymphoma: A prospective study
    • Seto, W. K. et al. Hepatitis B reactivation in patients with previous hepatitis B virus exposure undergoing rituximab-containing chemotherapy for lymphoma: a prospective study. J. Clin. Oncol. 32, 3736-3743 (2014).
    • (2014) J. Clin. Oncol. , vol.32 , pp. 3736-3743
    • Seto, W.K.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.